The work of Gaweł-Bęben K. et al. (2023) explored the in vitro anti-melanoma, anti-melanogenic, and anti-tyrosinase effects of CBD and other minor phytocannabinoids (CBG, CBN, and CBC). The gene discussed is TYR; the disease is melanoma.